{
  "id": "tumor-2a1068",
  "title": "Tumor Table Reference",
  "source": "tumor.html",
  "blocks": [
    {
      "type": "list",
      "items": [
        "Up to 5 tumor sites, maximum of 2 per organ.",
        "Bi-dimensional measurements; calculate sum of longest diameters (SLD).",
        "Choose target lesions easy to measure; identify non-target lesions (e.g., ascites/pleural fluid) to follow qualitatively.",
        "Tumors in lung, liver, solid organs: measure long axis. Lymph nodes: measure short axis."
      ]
    },
    {
      "type": "list",
      "items": [
        "Target lesions: determine SLD; include lymph nodes with short axis > 15 mm.",
        "Non-target lesions: <10 mm lesions, pleural fluid, ascites, etc.",
        "Follow-up assesses disappearance, stability, or progression."
      ]
    },
    {
      "type": "paragraph",
      "text": "Absolute SLD increase should be >5 mm to call progression."
    },
    {
      "type": "list",
      "items": [
        "Tumors: choose large, well-defined lesions; longest diameter >10 mm.",
        "Lymph nodes: short axis >15 mm can be targets.",
        "Examples: liver mets (include hypervascular rim), bone mets only if soft tissue component; sclerotic lesions not suited for targets; mediastinal LN short axis >15 mm; lung metastasis >10 mm; inguinal LN short axis >15 mm.",
        "Lymph nodes <10 mm normal; 10?\"14 mm pathologic but not target; can be non-target. If target nodes shrink to normal, still include measurement."
      ]
    },
    {
      "type": "list",
      "items": [
        "Immune therapy: pseudolesions may occur.",
        "Targeted therapy/Choi criteria: partial response if >15% decrease in tumor attenuation and >10% decrease in size.",
        "PERCIST (PET/CT): tumor size %1 cm; response if >30% decrease in max SUV; progression if >30% increase.",
        "Special staging: HCC response when arterial enhancement absent; GIST pseudoprogression?\"use attenuation and PET response (imatinib). %15% attenuation decrease may indicate response even if size increases."
      ]
    }
  ]
}
